Related Experiment Video
Updated: Jul 28, 2026
15:45
Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Hemodynamic and catecholamine changes after administration of naloxone
Anesthesia and Analgesia
|April 1, 1982
Summary
Intravenous naloxone, a medication, does not significantly alter blood pressure, heart rate, or catecholamine levels in surgical patients or healthy volunteers. This finding applies to both normotensive and hypertensive individuals.
Area of Science:
- Anesthesiology
- Pharmacology
- Cardiovascular Physiology
Background:
- Naloxone is an opioid antagonist used clinically.
- Its effects on hemodynamics and catecholamines in humans, particularly in surgical and volunteer populations, require clarification.
- Understanding these effects is crucial for safe clinical application.
Purpose of the Study:
- To investigate the hemodynamic and catecholamine responses to intravenous naloxone administration.
- To compare these responses in surgical patients (normotensive and hypertensive) and healthy volunteers (normotensive and hypertensive).
Main Methods:
- Two doses of naloxone (0.2 mg and 0.4 mg IV) were administered sequentially to participants.
- Hemodynamic parameters (mean arterial pressure, heart rate) and plasma catecholamine levels (norepinephrine, epinephrine, dopamine) were measured.
- Participants included surgical patients under anesthesia and unanesthetized volunteers, both normotensive and hypertensive.
Main Results:
- No statistically significant changes were observed in mean arterial pressure, heart rate, or plasma catecholamine levels in any of the study groups.
- This lack of significant alteration was consistent across normotensive and hypertensive individuals, as well as surgical patients and volunteers.
Conclusions:
- Intravenous naloxone, administered at the studied doses, does not appear to significantly affect hemodynamic parameters or plasma catecholamine levels in humans.
- These findings suggest that naloxone, per se, has a neutral effect on cardiovascular function and sympathetic nervous system activity in the investigated populations.
More Related Videos
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...